Immatics Market Cap from 2010 to 2024

IMTXW Stock  USD 0.41  0.01  2.38%   
Immatics Biotechnologies Market Cap yearly trend continues to be fairly stable with very little volatility. Market Cap will likely drop to about 480.3 M in 2024. During the period from 2010 to 2024, Immatics Biotechnologies Market Cap regression line of quarterly data had mean square error of 7515.2 T and geometric mean of  553,166,296. View All Fundamentals
 
Market Cap  
First Reported
2010-12-31
Previous Quarter
767.3 M
Current Value
480.3 M
Quarterly Volatility
87.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Immatics Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immatics Biotechnologies' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 13.7 M or Interest Income of 14.5 M, as well as many indicators such as Price To Sales Ratio of 13.5, Dividend Yield of 0.0 or PTB Ratio of 3.58. Immatics financial statements analysis is a perfect complement when working with Immatics Biotechnologies Valuation or Volatility modules.
  
Check out the analysis of Immatics Biotechnologies Correlation against competitors.

Latest Immatics Biotechnologies' Market Cap Growth Pattern

Below is the plot of the Market Cap of immatics biotechnologies GmbH over the last few years. It is Immatics Biotechnologies' Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immatics Biotechnologies' overall financial position and show how it may be relating to other accounts over time.
Market Cap10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Immatics Market Cap Regression Statistics

Arithmetic Mean558,901,166
Geometric Mean553,166,296
Coefficient Of Variation15.63
Mean Deviation55,679,266
Median537,591,877
Standard Deviation87,347,068
Sample Variance7629.5T
Range343.6M
R-Value0.29
Mean Square Error7515.2T
R-Squared0.09
Significance0.29
Slope5,705,888
Total Sum of Squares106813.1T

Immatics Market Cap History

2024480.3 M
2023767.3 M
2022546.8 M
2021743.6 M
2020423.8 M
2019583.4 M

About Immatics Biotechnologies Financial Statements

Immatics Biotechnologies investors use historical fundamental indicators, such as Immatics Biotechnologies' Market Cap, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immatics Biotechnologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Market Cap767.3 M480.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immatics Stock Analysis

When running Immatics Biotechnologies' price analysis, check to measure Immatics Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics Biotechnologies is operating at the current time. Most of Immatics Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Immatics Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics Biotechnologies' price. Additionally, you may evaluate how the addition of Immatics Biotechnologies to your portfolios can decrease your overall portfolio volatility.